18, 2025 – The FDA has approved a new 5-in-1 shot to protect against ... involving over 4,800 people ages 10 to 25 years. These studies showed that the vaccine is effective, safe, and well ...
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage recommendations on Feb. 26.
Both the Finnish and the U.S. bird flu vaccines are made by CSL Seqirus but are different vaccines. In the summer, U.S.
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...